FDA OKs First Oral Drug for Crohn's Disease.

Item request has been placed!

Item request cannot be made.

Processing Request

Read Online Read More Add to Saved list

Additional Information
- Subject Terms:
  DRUG approval; CROHN'S disease; ORAL drug administration; UNITED States. Food & Drug Administration; JANUS kinases; NEUROTRANSMITTER uptake inhibitors; PHARMACEUTICAL industry; DISEASE remission; SYMPTOMS
- Abstract:
  The article discusses the Food & Drug Administration (FDA) approval of Rinvoq (upadacitinib) for the treatment of moderate to severe Crohn's disease in adults who has not responded or tolerated treatment with TNF blocker drugs. It discusses the significance of this approval, as Rinvoq becomes the first oral pill indicated for Crohn's disease. It further provides information about Crohn's disease as a chronic condition and describes the symptoms and patterns of the disease.